ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Abbisko Cayman Limited clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 38 studies whose lead sponsor is Abbisko Cayman Limited or the company grouped under it. 19 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 9, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare Abbisko Cayman with Jiangsu HengRui Medicine and CSPC Pharmaceutical Group →

Pipeline: 8 programs

Each counted once: 8 with a study Abbisko Cayman Limited leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Abbisko Cayman Limited’s own registered studies; Abbisko Cayman Limited’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Abbisko Cayman Limited’s studies test, most open studies first — 8 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

3 of Abbisko Cayman Limited’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. 1M
  6. A
  7. M
  8. 1J
  9. 1J
  10. A
  11. S
  12. O
  13. N

Add all 3 to your calendar (.ics) → With an account.

All 38 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1950%Recruiting 14 · Not yet recruiting 3 · Enrolling by invitation 2
  • Under way, not recruiting513%
  • Completed1232%
  • Status unknown or other25%

Phase

  • Phase 127
  • Phase 213
  • Phase 31

Where

  • China37
  • United States6
  • Taiwan2
  • Spain1
  • Netherlands1
  • Canada1

Over the years

  1. 20
  2. 21
  3. 22
  4. 23
  5. 24
  6. 1125
  7. 426

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Abbisko Cayman Limited.

  • Abbisko Therapeutics Co, Ltd
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    38 studies →

Studies

Recruiting first, then most recently updated. Showing 38 of 38.